TAVAPADON, AN ORALLY ADMINISTERED, ONCE-DAILY, SELECTIVE D1/ D5 PARTIAL DOPAMINE AGONIST FOR ADJUNCTIVE TREATMENT OF PARKINSON'S DISEASE WITH MOTOR FLUCTUATIONS Meeting Abstract (Web of Science)

Industry Collaboration

cited authors

  • Fernandez, H. H.; Isaacson, S. H.; Hauser, R. A.; Agarwal, P.; Ondo, W.; Park, A.; Elmer, L.; Kremens, D.; Leoni, M.; Duvvuri, S.; Combs, C.; Koenig, E.; Chang, I.; Pastino, G.; Tringali, S.; Golonski, N.; Sanchez, R.

publication date

  • May 1, 2025

webpage

published in

category

volume

  • 134